In sickle cell anemia there are three primary mechanisms of pain arousal; nociceptive, peripheral neuropathic and central neuropathic pain. Inflammation or mechanical tissue pain is the underlying ...

Figure 3 outlines an algorithm, which illustrates an approach to the infant with anemia. Table 7 shows ... evaluated on a peripheral smear May be a normal variation in neonates.

The Pediatric Emergency Medicine and Pediatric Hematology/Oncology divisions at MUSC have joined forces to create and test an ...

For the first time in his life, a young New Jersey man is pain-free thanks to a new gene treatment working to cure patients ...

For 21 years, Sebastien Beauzile lived with the chronic pain of sickle cell anemia. Now, thanks to a groundbreaking genetic treatment, he is the first person in New York to be cured of the disease.

A 30-year-old New Jersey woman was charged with two felonies after police said she lied about having sickle cell anemia and refused to pay for over $560,000 in treatment from a hospital in Lancaster ...

Fewer ED visits per year and fewer hospital days per year seen in association with hydroxyurea use. HealthDay News — For children with sickle cell anemia (SCA), hydroxyurea has sustained ...

Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access ...

Background: The Multicenter Study of Hydroxyurea (HU) in Sickle Cell Anemia (MSH) previously showed that daily oral HU reduces painful sickle cell (SS) crises by 50% in patients with moderate to ...

WEST MONROE, La. (KTVE/KARD) — Today on Louisiana Living, Ashley Doughty is joined by Lonnikia Robinson to describe the upcoming Walk-A-Thon. For more information, watch the video above ...

"Sickle cell largely affects patients from African and African-Caribbean backgrounds, who are less likely to have a matching stem cell donor, and this community has been waiting years for a new ...